Literature DB >> 24636207

Circulating tumour cells: telling the truth about metastasis.

Massimo Cristofanilli1.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24636207     DOI： 10.1016/S1470-2045(14)70091-9

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  8 in total

1.  Diagnostic Value of Different Phenotype Circulating Tumor Cells in Hepatocellular Carcinoma.

Authors:  Yuan Cheng; Lei Luo; Juqiang Zhang; Mantian Zhou; Yujun Tang; Guolin He; Yishi Lu; Zhong Wang; MingXin Pan
Journal:  J Gastrointest Surg       Date:  2019-02-25       Impact factor: 3.452

2.  HER2-targeted therapy influences CTC status in metastatic breast cancer.

Authors:  Thomas M Deutsch; Sabine Riethdorf; Carlo Fremd; Manuel Feisst; Juliane Nees; Chiara Fischer; Andreas D Hartkopf; Klaus Pantel; Andreas Trumpp; Florian Schütz; Andreas Schneeweiss; Markus Wallwiener
Journal:  Breast Cancer Res Treat       Date:  2020-05-20       Impact factor: 4.872

3.  Three-dimensional nanostructured substrates enable dynamic detection of ALK-rearrangement in circulating tumor cells from treatment-naive patients with stage III/IV lung adenocarcinoma.

Authors:  Weiling He; Di Xu; Zhuo Wang; Hui Wu; Xianhong Xiang; Bing Tang; Wenting Jiang; Yongmei Cui; Han Wang; Neng Jiang; Yu Sun; Yangshan Chen; Shuhua Li; Minzhi Hou; Yang Zhang; Liantang Wang; Zun-Fu Ke
Journal:  J Transl Med       Date:  2019-01-18       Impact factor: 5.531

4.  Circulating miR-200 Family and CTCs in Metastatic Breast Cancer before, during, and after a New Line of Systemic Treatment.

Authors:  Chiara Fischer; Andrey Turchinovich; Manuel Feisst; Fabian Riedel; Kathrin Haßdenteufel; Philipp Scharli; Andreas D Hartkopf; Sara Y Brucker; Laura Michel; Barbara Burwinkel; Andreas Schneeweiss; Markus Wallwiener; Thomas M Deutsch
Journal:  Int J Mol Sci       Date:  2022-08-23       Impact factor: 6.208

Review 5.  Clinical and biological significance of circulating tumor cells, circulating tumor DNA, and exosomes as biomarkers in colorectal cancer.

Authors:  Shiyu Jia; Rui Zhang; Ziyang Li; Jinming Li
Journal:  Oncotarget       Date:  2017-04-18

6.  Correlation Between Postoperative Early Recurrence of Hepatocellular Carcinoma and Mesenchymal Circulating Tumor Cells in Peripheral Blood.

Authors:  Zhong Wang; Lei Luo; Yuan Cheng; Guolin He; Bangjian Peng; Yi Gao; Ze-Sheng Jiang; MingXin Pan
Journal:  J Gastrointest Surg       Date:  2017-11-20       Impact factor: 3.452

7.  Pre-metastatic niche triggers SDF-1/CXCR4 axis and promotes organ colonisation by hepatocellular circulating tumour cells via downregulation of Prrx1.

Authors:  Yujun Tang; Yishi Lu; Yuan Chen; Lei Luo; Lei Cai; Bangjian Peng; Wenbin Huang; Hangyu Liao; Liang Zhao; Mingxin Pan
Journal:  J Exp Clin Cancer Res       Date:  2019-11-21

8.  Untargeted longitudinal analysis of a wellness cohort identifies markers of metastatic cancer years prior to diagnosis.

Authors:  Andrew T Magis; Noa Rappaport; Matthew P Conomos; Gilbert S Omenn; Jennifer C Lovejoy; Leroy Hood; Nathan D Price
Journal:  Sci Rep       Date:  2020-10-01       Impact factor: 4.379
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.